MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 373 filers reported holding MEDIVATION INC in Q2 2015. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,926,000 | +7.9% | 114,864 | -17.7% | 0.01% | +12.5% |
| Q1 2016 | $6,420,000 | -8.0% | 139,633 | -3.3% | 0.01% | -11.1% |
| Q4 2015 | $6,978,000 | +15.2% | 144,354 | +1.3% | 0.01% | +12.5% |
| Q3 2015 | $6,059,000 | -21.9% | 142,566 | +109.8% | 0.01% | -20.0% |
| Q2 2015 | $7,759,000 | -3.2% | 67,938 | +9.5% | 0.01% | 0.0% |
| Q1 2015 | $8,012,000 | +53.1% | 62,071 | +18.2% | 0.01% | +42.9% |
| Q4 2014 | $5,232,000 | +20.7% | 52,529 | +19.9% | 0.01% | +16.7% |
| Q3 2014 | $4,333,000 | +27.8% | 43,822 | -0.4% | 0.01% | +20.0% |
| Q2 2014 | $3,390,000 | +98.1% | 43,977 | +65.5% | 0.01% | +150.0% |
| Q1 2014 | $1,711,000 | +4.9% | 26,577 | +4.0% | 0.00% | 0.0% |
| Q4 2013 | $1,631,000 | +4.6% | 25,551 | -1.8% | 0.00% | -33.3% |
| Q3 2013 | $1,559,000 | +23.9% | 26,008 | +1.7% | 0.00% | +50.0% |
| Q2 2013 | $1,258,000 | – | 25,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |